NHS Breast Cancer Drug Talks Resume After Three Years Of Failed Negotiations
Revised spending thresholds give fresh impetus to discussions over Enhertu, which has been blocked from the health service despite approval in Scotland and across Europe
By
Distilled Post Editorial Team